UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.. 20549
------------------------
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
Amendment No. 1*
NATIONAL DIAGNOSTICS, INC.
- --------------------------------------------------------------
(Name of Issuer)
Common Stock, No Par Value
- --------------------------------------------------------------
(Title of Class of Securities)
635641 10 3
- ---------------------------------------------------------------
(CUSIP number)
John I. Van Voris
Shackleford, Farrior, Stallings & Evans, P.A.
P.O. Box 3324
Tampa, FL 33601
(813) 273-5046
- --------------------------------------------------------------
(Name, address and telephone number of person
authorized to receive notices and communications)
August 5, 1998
- ----------------------------------------------------------
(Date of event which requires filing of this statement)
If the filing person has previously filed a statement on
Schedule 13G to report the acquisition which is the subject of
this Schedule 13D, and is filing this schedule because of Rule
13D-1(b)(3) or (4), check the following box [ ].
Note. Six copies of this statement, including all exhibits,
should be filed with the Commission. See Rule 13d-1(a) for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in
a prior cover page.
<PAGE>
<PAGE>
CUSIP No. 635641 10 3 13D/A Page 2 of 6 Pages
The information required on the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).
- -----------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
JUGAL K. TANEJA SS No. ###-##-####
- -----------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(A) [ ]
(B) [ ]
- -----------------------------------------------------------------
3 SEC USE ONLY
- -----------------------------------------------------------------
4 SOURCE OF FUNDS: PF AND AF
- -----------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO
ITEM 2(d) OR 2(e) [ ]
- -----------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION: UNITED STATES OF
AMERICA
- -----------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER: 815,700
SHARES --------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER: 0
OWNED BY --------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER: 815,700
REPORTING --------------------------------------------
PERSON WITH 10 SHARED DISPOSITIVE POWER: 0
--------------------------------------------
- -----------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON: 815,700
- -----------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- -----------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11): 9.2%
- -----------------------------------------------------------------
14 TYPE OF REPORTING PERSON: IN
- -----------------------------------------------------------------
<PAGE>
<PAGE>
CUSIP No. 635641 10 3 13D/A Page 3 of 6 Pages
This amends and restates the Schedule 13D filed by Jugal K.
Taneja with the Securities and Exchange Commission on November 7,
1996. This amendment is filed to reflect the sale of common
stock of National Diagnostics, Inc. ("National").
ITEM 1. SECURITY AND ISSUER
This statement relates to the Common Stock, no par value
("Common Stock"), of National Diagnostics, Inc., a Florida
corporation ("National"). National's principal executive offices
are located at 747 West Brandon Blvd., Brandon, Florida 33511.
The second sentence of Item 1 is hereby amended to read as
follows:
National's principal executive offices are located at
755 West Brandon Blvd., Brandon, Florida 33511.
ITEM 2. IDENTITY AND BACKGROUND
This report is filed on behalf of Jugal K. Taneja
("Taneja"). Mr. Taneja's business address is 747 West Brandon
Blvd., Brandon, Florida 33511. Mr. Taneja's current principal
occupation is as the Chief Executive Officer of NuMed Home Health
Care, Inc. Mr. Taneja also serves as the Chief Executive Officer
of the Issuer, National Diagnostics, Inc. Mr. Taneja is a
citizen of the United States and is a resident of the State of
Florida.
Taneja has not, during the last five years, (i) been
convicted in a criminal proceeding (excluding traffic violations
or similar misdemeanors), or (ii) been a party to a civil
proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject
to a judgment, decree or final order enjoining future violations
of, or prohibiting or mandating activities subject to, federal or
state securities laws or finding any violation with respect to
such laws.
The first paragraph of Item 2 is hereby amended to read as
follows:
This report is filed on behalf of Jugal K. Taneja
("Taneja"). Mr. Taneja's business address is 5770 Roosevelt
Blvd., Suite 700, Clearwater, Florida 34620. Mr. Taneja's
current principal occupation is as the Chief Executive
Officer of NuMed Home Health Care, Inc. Mr. Taneja is no
longer an officer or director of National. Mr. Taneja is a
citizen of the United States and is a resident of the State
of Florida.
<PAGE>
<PAGE>
CUSIP No. 635641 10 3 13D/A Page 4 of 6 Pages
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATIONS
There were no purchases made pursuant to this filing.
ITEM 4: PURPOSE OF TRANSACTION
Mr. Taneja has acquired his interest in National as an
investment and acquired his shares with a view toward making a
profit.
ITEM 5. INTEREST IN THE SECURITIES OF THE ISSUER
(a) Aggregate Number and Percentage of Securities:
---------------------------------------------
Mr. Taneja is the beneficial owner of 1,020,000 shares
of Common Stock, representing approximately 38.8% of
the class based upon the number of Common Shares
reported as outstanding (excluding Treasury Shares) as
of November 7, 1996.
(b) Power to Vote and Dispose:
---------------------------------------------
Mr. Taneja has sole power to vote and dispose of
1,020,000 shares of Common Stock. Mr. Taneja shares no
voting or disposition power. This amount includes
beneficial ownership of (i) 100,000 Common Shares owned
by First Delhi Trust, a trust for Mr. Taneja's children
over which he exercises voting rights and (ii) 720,000
shares of Common Stock owned by Twenty-First Century
Healthcare Fund, L.L.C., a limited liability company
controlled by Mr. Taneja and his family members. This
amount excludes 84,000 shares beneficially owned by his
wife, Manju Taneja, as to which Mr. Taneja exercises no
voting or disposition rights and as to which Mr. Taneja
disclaims beneficial ownership.
(c) Transactions Within the Past 60 Days:
---------------------------------------------
On October 8, 1996, Taneja gifted 720,000 Common Shares
to the family controlled Twenty-First Century
Healthcare Fund, L.L.C.
(d) Certain Rights of Other Persons:
---------------------------------------------
Not applicable.
(e) Date Ceased to be 5% Owner:
---------------------------------------------
Not applicable.
Item 5(a)-(c) is hereby amended to read as follows:
(a) Aggregate Number and Percentage of Securities.
---------------------------------------------
Mr. Taneja is the beneficial owner of 815,700 shares of
National's Common Stock, representing approximately 9.2
percent of the class based upon the number of shares of
Common Stock reported as outstanding (excluding Treasury
Shares) as of June 30, 1998.
(b) Power to Vote and Dispose:
---------------------------------------------
Mr. Taneja has sole power to vote and dispose of
815,700 shares of National's Common Stock. Mr. Taneja
shares no voting or disposition power. This amount includes
beneficial ownership of (i) 200,000 shares owned of record
by Mr. Taneja and (ii) 615,700 shares owned by Twenty-First
Century Healthcare Fund, L.L.C., a limited liability company
controlled by Mr. Taneja and family members.
<PAGE>
<PAGE>
CUSIP No. 635641 10 3 13D/A Page 5 of 6 Pages
(c) Transactions Within the Past 60 Days:
---------------------------------------------
The following table describes the transactions in
National's Common Stock by Mr. Taneja during the past 60
days.
<PAGE>
<TABLE>
How
Price Transaction
Seller Sales Date No. of Shares Per Share Effected
- ---------------- ---------- ------------- --------- ------------
<S> <C> <C> <C> <C>
First Delhi Trust 08/10/98 30,200 $0.938 OTC BB
Twenty-First Century 08/13/98 38,300 0.960 OTC BB
Healthcare Fund, L.L.C.
Twenty-First Century 09/25/98 38,000 0.648 OTC BB
Healthcare Fund, L.L.C.
Twenty-First Century 09/29/98 28,000 0.779 OTC BB
Healthcare Fund, L.L.C.
</TABLE>
<PAGE>
ITEM 6: CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR
RELATIONSHIPS WITH RESPECT TO SECURITIES OF
THE ISSUER
None.
ITEM 7: MATERIAL TO BE FILED AS EXHIBITS
None.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
Dated: October 9, 1998
/s/ Jugal K. Taneja
---------------------------
Name: Jugal K. Taneja
SF: 316179
